Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5698210 | Clinical Oncology | 2015 | 7 Pages |
Abstract
In everyday clinical practice, retreatment for painful bone metastases leads to pain reduction in 66% of evaluable patients and 43% of patients in a worst-case analysis. Patients who responded to initial radiotherapy were more likely to respond again and those on systemic therapy were less likely to respond. Overall, repeat radiotherapy should be considered in patients with persisting bone pain.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
M. Huisman, H.M. Verkooijen, Y.M. van der Linden, M.A.A.J. van den Bosch, M. van Vulpen,